Inside Quantum Technology - Get The Latest Quantum News & Events Here

What is next step in emerging market development after the “Market Pull” discussed in last week’s Market Pull for Quantum Chemicals and Quantum Life Science article published last week?

In business and economic development, the next step in emerging market development after initial “Market Pull” successes is typically a broader shift toward the Scaling and Operational Excellence Phase. [ 1, 2, 3]

When an emerging market or startup validates local demand through market pull (solving immediate customer pain points), it establishes an initial foothold. However, to avoid hitting a ceiling of incrementalism, the development must evolve through the following stages of Scaling and Operational Excellence: [1, 2]

Steps in Scaling and Operational Excellence

1. Pivot to Process Innovation
2. Institutional Scaling
3. Financial Deepening

IQT Quantum Chemicals and Quantum Life Science will describe each of these three steps and give examples of what is occurring in each stop for 1) quantum chemicals and 2) quantum life science.

1. The Pivot to Process Innovation

While market pull is excellent for early adoption, relying on it entirely can lead to short-termism and copycat competition. Once early successes are secured, firms must shift inward to build core technical capabilities: [1, 2]

In this stage, corporations stop viewing quantum tech purely as a tool for creating “new products” (exploratory) and instead integrate it into existing R&D pipelines to optimize efficiency, lower operational costs, and accelerate discovery timelines ( [1, 2]

Examples of Process Innovation in Quantum Chemicals

Quantum Chemistry: Industrial chemical conglomerates are using hybrid quantum-classical algorithms (like VQE—Variational Quantum Eigensolver) to optimize catalysts and materials synthesis. Rather than replacing classical software, they hook quantum cloud platforms directly into existing high-performance computing (HPC) workflows.

• • Corporate Examples
  • : BASF and Dow Chemical partner with quantum software firms to model chemical processes like nitrogen fixation or polymer degradation, aiming to compress catalytic research timeframes from years to weeks. [1]

  • Examples of Process Innovation in Quantum Life Science

  • Corporate Example: Boehringer Ingelheim partnered with Google Quantum AI to integrate simulation into their established workflows targeting electructure calculations of complex disease proteins.

• • 2. Institutional Scaling

Quantum technology is transitioning from theoretical physics into highly specialized commercial fields.  Institutional Scaling (expanding organizational structures, partnerships, and computing infrastructure) and Financial Deepening (expanding capital access, liquidity, and specialized financial instruments) apply to both quantum chemistry and quantum life sciences.

On a macroeconomic scale, individual market-pull successes trigger the transition into an institutionalized and scaling growth ecosystem: [1]

• Formalization: Moving from informal, fragmented distribution networks to structured, formal retail, digital infrastructure, and logistics ecosystems. [1]
• Resource and Capital Reallocation: Scaling up operations by moving assets from exploratory local projects into highly standardized, repeatable business models to achieve industrial scale. [1, 2]

Institutional Scaling in Quantum Chemicals

Institutional Scaling:

• Example: The establishment of industrial-academic consortiums to pool expensive high-performance quantum computing (HPQC) resources. For instance, chemical conglomerates like BASF or Dow collaborating with government labs and quantum providers (e.g., IBM Quantum Network) to scale hardware capabilities specifically for simulating catalysts and new polymers.
• Impact: Individual companies don’t need to build private quantum mainframes; instead, institutional frameworks share the infrastructure burden to scale up the complexity of simulated molecules.

Because simulating molecules natively scales exponentially on classical hardware, no single institution possesses the capital, hardware infrastructure, or domain expertise to solve these bottlenecks alone. Key institutional scaling models and examples include: [1, 2]

• The ARQUIN Framework (C2QA): Led by the Pacific Northwest National Laboratory (PNNL) and involving 14 institutions (including MIT, Yale, and IBM), this Department of Energy-backed initiative co-designed a multi-node quantum architecture. It breaks down large-scale distributed quantum workloads into specialized algorithmic and hardware layers specifically targeting complex chemical system bottlenecks. [1, 2]
• The Quantum Scaling Alliance (QSA): Co-led by HPE Labs and pioneer John Martinis, this multi-organization consortium leverages the semiconductor and supercomputing ecosystem to scale quantum computing infrastructure into practical chemistry applications. [1]

Governments and major tech enterprises are scaling chemical computation to address localized and global environmental threats. [1]

• The PFAS Remediation Coalition: In a massive cross-sector initiative, Amazon (Global Impact Computing team), Accenture, Intel, and Good Chemistry scaled up the QEMIST Cloud By linking quantum chemical software with massive high-performance computing (HPC) environments, they expanded the bounds of simulating reactions to systematically “design out” toxic per- and polyfluoroalkyl substances (PFAS). [1, 2, 3]

Institutional Scaling Examples in Quantum Life Science

Institutional scaling

Institutional scaling in quantum life sciences has officially transitioned from isolated academic experiments to structured, heavily funded global infrastructures. Governments, multinational pharmaceutical companies, tech giants, and healthcare systems are building a permanent ecosystem to transition quantum biology, sensing, and molecular simulation out of the lab and into industrial Pipelines. [1, 2, 3]

Instead of just buying cloud access, major healthcare systems are building physical quantum hubs to run massive biological models.

• The Cleveland Clinic, IBM, and RIKEN Alliance: This partnership scales quantum hardware specifically for biological benchmarks. They achieved a milestone by simulating a 12,635-atom protein—the largest quantum-centric molecular simulation ever completed—using quantum-centric supercomputing architectures to model real-world biological systems.[
• Algorithmiq & Cleveland Clinic Cancer Research: Scaled via IBM’s Q4Bio initiative, this team uses fault-tolerant quantum algorithms with deep gate circuits (>50 qubits) to simulate molecular processes in photodynamic therapy for cancer treatments. [1]

3. Financial Deepening:

Financial Deepening Defined:

Financial Deepening in Quantum Chemicals

Financial deepening in quantum chemistry refers to the rapid maturation, diversification, and scaling of capital moving into the quantum-powered molecular simulation and materials science sectors. Once considered a theoretical academic pursuit, quantum chemistry is experiencing a massive wave of capital deployment from corporate venture capital (CVC), sovereign funds, institutional project finance, and public grants. [1, 2, 3]

Unlike other quantum computing applications (like cryptographic breaking or complex financial optimization) that require millions of fault-tolerant qubits, chemistry can achieve a “quantum advantage” much sooner. Early fault-tolerant or heavily error-mitigated processors (around 1,000 logical qubits) can map electron interactions and simulate molecular structures directly. Consequently, investors see an immediate commercial runway to disrupt a mature market. McKinsey estimates that transitioning from physical “wet labs” to digital quantum simulations could unlock $200 billion to $500 billion in economic value by 2035.

Financial Deepening in Quantum Life Science